Conquering rheumatic diseases: are parasitic worms the answer?

Goldblatt, 2013, Clinical aspects of autoimmune rheumatic diseases, Lancet, 382, 797, 10.1016/S0140-6736(13)61499-3 Giacomelli, 2019, Guidelines for biomarkers in autoimmune rheumatic diseases – evidence based analysis, Autoimmun. Rev., 18, 93, 10.1016/j.autrev.2018.08.003 Weyand, 2021, The immunology of rheumatoid arthritis, Nat. Immunol., 22, 10, 10.1038/s41590-020-00816-x Yap, 2018, Pathogenic role of immune cells in rheumatoid arthritis: implications in clinical treatment and biomarker development, Cells, 7, 161, 10.3390/cells7100161 Jang, 2022, Rheumatoid arthritis: pathogenic roles of diverse immune cells, Int. J. Mol. Sci., 23, 905, 10.3390/ijms23020905 Samuels, 2005, Impaired early B cell tolerance in patients with rheumatoid arthritis, J. Exp. Med., 201, 1659, 10.1084/jem.20042321 Lefevre, 2015, Role of synovial fibroblasts in rheumatoid arthritis, Curr. Pharm. Des., 21, 130, 10.2174/1381612820666140825122036 Herrada, 2019, Innate immune cells' contribution to systemic lupus erythematosus, Front. Immunol., 10, 772, 10.3389/fimmu.2019.00772 Feng, 2020, The pathological role of B cells in systemic lupus erythematosus: from basic research to clinical, Autoimmunity, 53, 56, 10.1080/08916934.2019.1700232 Wilbrink, 2021, B cell involvement in the pathogenesis of ankylosing spondylitis, Int. J. Mol. Sci., 22, 10.3390/ijms222413325 Rath, 2010, Drug combinations with methotrexate to treat rheumatoid arthritis, Clin. Exp. Rheumatol., 28, S52 Chen, 2013, Methotrexate for ankylosing spondylitis, Cochrane Database Syst. Rev., 4 Sakthiswary, 2014, Methotrexate in systemic lupus erythematosus: a systematic review of its efficacy, Lupus, 23, 225, 10.1177/0961203313519159 Fraenkel, 2021, 2021 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis, Arthritis Rheumatol., 73, 1108, 10.1002/art.41752 Maciejewski, 2021, Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomics, Sci. Rep., 11, 7266, 10.1038/s41598-021-86729-7 Wang, 2018, Side effects of methotrexate therapy for rheumatoid arthritis: a systematic review, Eur. J. Med. Chem., 158, 502, 10.1016/j.ejmech.2018.09.027 Lian, 2018, Relapsing course of sulfasalazine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) complicated by alopecia universalis and vitiligo, Ann. Acad. Med. Singap., 47, 492, 10.47102/annals-acadmedsg.V47N11p492 Tarp, 2016, Risk of serious adverse effects of biological and targeted drugs in patients with rheumatoid arthritis: a systematic review meta-analysis, Rheumatology, 56, 417 Al Farii, 2021, The effect of NSAIDs on postfracture bone healing: a meta-analysis of randomized controlled trials, OTA Int., 4, 10.1097/OI9.0000000000000092 van Esch, 2013, NSAIDs can have adverse effects on bone healing, Med. Hypotheses, 81, 343, 10.1016/j.mehy.2013.03.042 Naesdal, 2006, NSAID-associated adverse effects and acid control aids to prevent them, Drug Saf., 29, 119, 10.2165/00002018-200629020-00002 Wilson, 2019, Incidence and risk of glucocorticoid-associated adverse effects in patients with rheumatoid arthritis, Arthritis Care Res., 71, 498, 10.1002/acr.23611 Aletaha, 2003, Toxicity profiles of traditional disease modifying antirheumatic drugs for rheumatoid arthritis, Ann. Rheum. Dis., 62, 482, 10.1136/ard.62.5.482 Ramírez, 2018, Anakinra for the treatment of rheumatoid arthritis: a safety evaluation, Expert Opin. Drug Saf., 17, 727, 10.1080/14740338.2018.1486819 Cagnotto, 2020, Abatacept in rheumatoid arthritis: survival on drug, clinical outcomes, and their predictors – data from a large national quality register, Arthritis Res. Ther., 22, 15, 10.1186/s13075-020-2100-y Tanaka, 2014, Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors, Biologics, 8, 141 Garcia-Montoya, 2020, Lessons for rituximab therapy in patients with rheumatoid arthritis, Lancet Rheumatol., 2, e497, 10.1016/S2665-9913(20)30033-3 Min, 2022, Therapeutic utility and adverse effects of biologic disease-modifying anti-rheumatic drugs in inflammatory arthritis, Int. J. Mol. Sci., 23, 13913, 10.3390/ijms232213913 Strachan, 1989, Hay fever, hygiene, and household size, BMJ, 299, 1259, 10.1136/bmj.299.6710.1259 Rook, 2005, Old friends for breakfast, Clin. Exp. Allergy, 35, 841, 10.1111/j.1365-2222.2005.02112.x Pineda, 2012, The parasitic helminth product ES-62 suppresses pathogenesis in collagen-induced arthritis by targeting the interleukin-17-producing cellular network at multiple sites, Arthritis Rheum., 64, 3168, 10.1002/art.34581 Panda, 2013, Rheumatoid arthritis patients are free of filarial infection in an area where filariasis is endemic: comment on the article by Pineda et al, Arthritis Rheum., 65, 1402, 10.1002/art.37883 Zaccone, 2006, Parasitic worms and inflammatory diseases, Parasite Immunol., 28, 515, 10.1111/j.1365-3024.2006.00879.x Otón, 2019, The epidemiology of established rheumatoid arthritis, Best Pract. Res. Clin. Rheumatol., 33, 10.1016/j.berh.2019.101477 Finckh, 2022, Global epidemiology of rheumatoid arthritis, Nat. Rev. Rheumatol., 18, 591 Fatoye, 2022, Global and regional prevalence and incidence of systemic lupus erythematosus in low-and-middle income countries: a systematic review and meta-analysis, Rheumatol. Int., 42, 2097, 10.1007/s00296-022-05183-4 Tian, 2023, Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study, Ann. Rheum. Dis., 82, 351, 10.1136/ard-2022-223035 Crossfield, 2021, Changes in ankylosing spondylitis incidence, prevalence and time to diagnosis over two decades, RMD Open, 7, 10.1136/rmdopen-2021-001888 McDougall, 2017, Systematic review of rheumatic disease epidemiology in the indigenous populations of Canada, the United States, Australia, and New Zealand, Semin. Arthritis Rheum., 46, 675, 10.1016/j.semarthrit.2016.10.010 Hitchon, 2020, Prevalence and incidence of rheumatoid arthritis in Canadian First Nations and non-First Nations people: a population-based study, J. Clin. Rheumatol., 26, 169, 10.1097/RHU.0000000000001006 Panda, 2017, Diminished IL-17A levels may protect filarial-infected individuals from development of rheumatoid arthritis and systemic lupus erythematosus, Lupus, 26, 348, 10.1177/0961203316662722 Cheng, 2022, Bone erosion in inflammatory arthritis is attenuated by Trichinella spiralis through inhibiting M1 monocyte/macrophage polarization, iScience, 25, 10.1016/j.isci.2022.103979 Cheng, 2018, Trichinella spiralis infection mitigates collagen-induced arthritis via programmed death 1-mediated immunomodulation, Front. Immunol., 9, 1566, 10.3389/fimmu.2018.01566 Shayesteh, 2020, Evaluating the preventive and curative effects of Toxocara canis larva in Freund's complete adjuvant-induced arthritis, Parasite Immunol., 42, 10.1111/pim.12760 Li, 2020, The impact of Clonorchis sinensis infection on immune response in mice with type II collagen-induced arthritis, BMC Immunol., 42 Olia, 2020, Suppression of systemic lupus erythematosus in NZBWF1 mice infected with Hymenolepis microstoma, Parasitol. Int., 76, 10.1016/j.parint.2020.102057 Miyake, 2014, Parasites alter the pathological phenotype of lupus nephritis, Autoimmunity, 47, 538, 10.3109/08916934.2014.929669 Buitrago, 2021, A netrin domain-containing protein secreted by the human hookworm Necator americanus protects against CD4 T cell transfer colitis, Transl. Res., 232, 88, 10.1016/j.trsl.2021.02.012 Langdon, 2022, Na-AIP-1 secreted by human hookworms suppresses collagen-induced arthritis, Inflammopharmacology, 30, 527, 10.1007/s10787-021-00909-5 Khatri, 2020, Parasite cystatin: immunomodulatory molecule with therapeutic activity against immune mediated disorders, Pathogens, 9, 431, 10.3390/pathogens9060431 Liu, 2016, Schistosoma japonicum cystatin attenuates murine collagen-induced arthritis, Parasitol. Res., 115, 3795, 10.1007/s00436-016-5140-0 Chen, 2021, Schistosoma japonicum cystatin suppresses osteoclastogenesis via manipulating the NF-κB signaling pathway, Mol. Med. Rep., 23, 273, 10.3892/mmr.2021.11912 Pineda, 2014, Lessons from helminth infections: ES-62 highlights new interventional approaches in rheumatoid arthritis, Clin. Exp. Immunol., 177, 13, 10.1111/cei.12252 McInnes, 2003, A novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein ES-62, J. Immunol., 171, 2127, 10.4049/jimmunol.171.4.2127 Rodgers, 2014, Protection against collagen-induced arthritis in mice afforded by the parasitic worm product, ES-62, is associated with restoration of the levels of interleukin-10-producing B cells and reduced plasma cell infiltration of the joints, Immunology, 141, 457, 10.1111/imm.12208 Pineda, 2014, ES-62 protects against collagen-induced arthritis by resetting interleukin-22 toward resolution of inflammation in the joints, Arthritis Rheumatol., 66, 1492, 10.1002/art.38392 Lumb, 2017, Dendritic cells provide a therapeutic target for synthetic small molecule analogues of the parasitic worm product, ES-62, Sci. Rep., 7, 1704, 10.1038/s41598-017-01651-1 Doonan, 2018, Protection against arthritis by the parasitic worm product ES-62, and its drug-like small molecule analogues, is associated with inhibition of osteoclastogenesis, Front. Immunol., 14, 1016, 10.3389/fimmu.2018.01016 Corbet, 2021, Suppression of inflammatory arthritis by the parasitic worm product ES-62 is associated with epigenetic changes in synovial fibroblasts, PLoS Pathog., 17, 10.1371/journal.ppat.1010069 Doonan, 2019, The parasitic worm product ES-62 normalises the gut microbiota bone marrow axis in inflammatory arthritis, Nat. Commun., 10, 1554, 10.1038/s41467-019-09361-0 Doonan, 2018, Failure of the anti-inflammatory parasitic worm product ES-62 to provide protection in mouse models of type I diabetes, multiple sclerosis, and inflammatory bowel disease, Molecules, 23, 2669, 10.3390/molecules23102669 Jubair, 2018, Modulation of inflammatory arthritis in mice by gut microbiota through mucosal inflammation and autoantibody generation, Arthritis Rheumatol., 70, 1220, 10.1002/art.40490 Zhang, 2015, The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment, Nat. Med., 21, 895, 10.1038/nm.3914 Xu, 2020, Regional differences in the gut microbiota and gut-associated immunologic factors in the ileum and cecum of rats with collagen-induced arthritis, Front. Pharmacol., 11, 10.3389/fphar.2020.587534 Harnett, 2022, The parasitic worm product ES-62 protects the osteoimmunology axis in a mouse model of obesity-accelerated ageing, Front. Immunol., 13, 10.3389/fimmu.2022.953053 Harnett, 2008, The phosphorycholine moiety of the filarial nematode immunomodulator ES-62 is responsible for its anti-inflammatory action in arthritis, Ann. Rheum. Dis., 67, 518, 10.1136/ard.2007.073502 Rodgers, 2015, The parasitic worm product ES-62 targets myeloid differentiation factor 88-dependent effector mechanisms to suppress antinuclear antibody production and proteinuria in MRL/lpr mice, Arthritis Rheumatol., 67, 1023, 10.1002/art.39004 Aprahamian, 2015, The immunomodulatory parasitic worm product ES-62 reduces lupus-associated accelerated atherosclerosis in a mouse model, Int. J. Parasitol., 45, 203, 10.1016/j.ijpara.2014.12.006 Frostegård, 2023, Systemic lupus erythematosus and cardiovascular disease, J. Intern. Med., 293, 48, 10.1111/joim.13557 Yang, 2021, Therapeutic effect of Schistosoma japonicum cystatin on atherosclerotic renal damage, Front. Cell Dev. Biol., 9, 10.3389/fcell.2021.760980 Harnett, 2010, How do nematodes transfer phosphorylcholine to carbohydrates?, Trends Parasitol., 26, 114, 10.1016/j.pt.2009.12.003 Kuriakose, 2016, Immunogenicity of biotherapeutics: causes and association with posttranslational modifications, J Immunol Res, 2016, 10.1155/2016/1298473 Rzepecka, 2015, Prophylactic and therapeutic treatment with a synthetic analogue of a parasitic worm product prevents experimental arthritis and inhibits IL-1β production via NRF2-mediated counter-regulation of the inflammasome, J. Autoimmun., 60, 59, 10.1016/j.jaut.2015.04.005 Al-Riyami, 2013, Designing anti-inflammatory drugs from parasitic worms: a synthetic small molecule analogue of the Acanthocheilonema viteae product ES-62 prevents development of collagen-induced arthritis, J. Med. Chem., 56, 9982, 10.1021/jm401251p Blank, 2018, Helminths-based bi-functional molecule, tuftsin-phosphorylcholine (TPC), ameliorates an established murine arthritis, PLoS One, 13, 10.1371/journal.pone.0200615 Neuman, 2019, Helminth-based product and the microbiome of mice with lupus, mSystems, 4, 10.1128/mSystems.00160-18 Khan, 2020, Fasciola helminth defense molecule-1 protects against experimental arthritis by inhibiting osteoclast formation and function without modulating the systemic immune response, FASEB J., 34, 1091, 10.1096/fj.201901480RR Rzepecka, 2022, Can the study of parasitic helminths be fruitful for human diseases?, 607 Makurvet, 2021, Biologics vs. small molecules: drug costs and patient access, Med. Drug Discov., 9, 10.1016/j.medidd.2020.100075